Directors | Robert A. Lutz, Chair of the board (appointed November 3, 2023) Jacqueline Dedo (appointed November 3, 2023) Burt Jordan (appointed November 3, 2023) Chris Leary (appointed February 23, 2024) Jonathan Magaziner (appointed February 23, 2024) Matti Masanovich (appointed November 3, 2023) Dale McKee (appointed November 3, 2023) Donald Hampton, Jr. (appointed March 19, 2025) Jake Dingle (resigned March 19, 2025) James Campbell Douglas (appointed November 3, 2023, resigned February 21, 2024) Lucia Estana Cade (appointed November 3, 2023, resigned February 21, 2024) Mark William Bernhard (appointed November 3, 2023, resigned February 21, 2024) Rolando Ebuna (resigned November 3, 2023) Ronan Donohoe (resigned November 3, 2023) | ||
Secretary | Bradwell Limited | ||
Registered office | 10 Earlsfort Terrace Dublin 2 D02 T380 Ireland | ||
Independent auditor | KPMG 1 Stokes Place St. Stephen’s Green Dublin 2 | ||
Bankers | Citi Commercial Bank, Australia Citigroup Centre 2 Park Street Sydney NSW 2000 Australia | ||
Solicitors | Arthur Cox LLP Ten Earlsfort Terrace Dublin 2 D02 T380 Ireland | ||
Registered number | 607450 | ||
• | The Company is not yet profitable or cash flow positive. The Company will need to raise additional capital to continue operating, and it may not be able to do so. |
• | The Company expects that it will need to refinance its long term debt, and may not be able to do so on acceptable terms, or at all. |
• | It may take longer for the Company to become cash flow breakeven or reach profitability than anticipated (or it may never occur). |
• | The Company could fail to meet the financial covenants under the New Debt Program (including the 2024 Amendments). |
• | The terms of the OIC Financing impose obligations on us or restrict our ability to engage in some business activities, which could materially adversely affect our business, results of operations and financial condition. |
• | In the event of certain triggers under the Company’s Amended and Restated Memorandum and Articles of Association and the certificate of designation of the Class B Preferred Shares, holders of Preferred Shares will gain certain governance and control rights. |
• | The Company has a limited operating history which does not provide a meaningful basis for investors to evaluate the business, financial performance and prospects. |
• | The Company’s customers may not order wheels as expected. |
• | Wheel programs warranting further expansion to a low cost manufacturing location may not be awarded or may not be awarded for the expected volumes or level of returns. |
• | Wheel programs may commence later than expected due to the design development and engineering phase taking longer than expected. |
• | The margin received by the Company for its wheels may be lower than expected. Similarly, the Company may not recover engineering and development or tooling costs from its customers to the extent expected. |
• | Due to industry standard contractual provisions which are favorable to the Company’s customers, the Company may be exposed to volatility in demand and changes to customer forecasts on short notice, resulting in disruption to the Company’s operations and supply chain and increased costs and lower margins. The Company may not be able to adjust its raw material supply orders on short notice to meet such demand, which may adversely affect the Company’s profitability, cash flow and operations. |
• | Ongoing support from PIUS and OIC of US$11.4 million (A$17.4 million), including: |
• | conditional access to US$5 million (A$7.6 million) of capital under the OIC financing arrangements (as per Notes 4 and 6); |
• | conditional access to US$0.4 million (A$0.7 million) of capital under the PIUS financing arrangement (as per Notes 4 and 6); |
• | moving from cash paid interest to Payment in Kind (“PIK”) interest from July 2025 to December 2025, which is worth approximately US$6m (A$9.1 million) |
• | OIC also has US$15million (A$22.7 million) of further funds available for investment in the Group, currently earmarked for future expansion opportunities. If the Group did require near term assistance after exhausting all other reasonable sources of liquidity, OIC may repurpose these funds to support the Group’s short-term liquidity needs, subject to OIC’s approval at the time. |
• | Its unrestricted cash balance of A$1.5 million at April 30, 2025; |
• | Access to capital through the issuance of debt or equity securities via public or private placement; and |
• | Access to capital under the Committed Equity Facility (“CEF”). |
• | Satisfying the conditions necessary to access the remaining US$5 million (A$7.6 million) of OIC funds and US$0.4 million (A$0.7 million) PIUS funds, along with moving from cash interest to PIK interest in the second half of CY25; |
• | Achieving forecast production levels, sales mix and pricing; |
• | Reducing unit costs, reducing fixed overheads and limiting non-contracted capital expenditures in accordance with cost reduction initiatives; |
• | Securing agreement for ongoing deferral of previously agreed transaction costs deferrals from the capital reorganization (as per Note 3.6.1) amounting to a total of US$15.0 million (A$22.5 million). Under an agreement the Group had reached with these creditors to delay payment, US$5 million (A$7.6 million) was payable in November 2024, with the remainder to be paid from the proceeds of certain fundraising transactions or on a straight line basis over 5 years (depending on the option selected by the supplier). The US$5 million (A$7.6 million) payment was not made in November 2024 and a further US$10.0 million |
• | Ongoing support from suppliers and customers in the form of favourable payment terms and bailment arrangements; |
• | Successful outcome of claims which the Group has made or plans to make against customers primarily associated with ordered volumes that are below the volumes which the Group was required to build and reserve capacity for under its customer contracts, and cancellation of a wheel program; and |
• | Raising capital to fund operations through the issuance of debt or equity securities via public or private placement (including through the CEF). |
• | drawing up of a compliance policy statement setting out the company's policies (that, in our opinion, are appropriate to the company) respecting compliance by the company with its relevant obligations; |
• | putting in place appropriate arrangements or structures (that, in our opinion) are, designed to secure material compliance with the company's relevant obligations; and |
• | conducting a review during the financial year of any arrangements or structures that have been put in place. |
![]() | ![]() | ||||||||
Dale McKee | Matti Masanovich | June 6, 2025 | |||||||
• | select suitable accounting policies and then apply them consistently; |
• | make judgements and estimates that are reasonable and prudent; |
• | state whether applicable Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; |
• | assess the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern; and |
• | use the going concern basis of accounting unless they either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so. |
![]() | ![]() | June 6,2025 | |||||||
Dale McKee | Matti Masanovich | ||||||||
Director | Director | ||||||||
![]() | KPMG Audit 1 Stokes Place St. Stephen’s Green Dublin 2 D02 DE03 Ireland | ||
• | the financial statements give a true and fair view of the assets, liabilities and financial position of the Group and Company as at 30 June 2024 and of the Group’s loss for the year then ended; |
• | the Group financial statements have been properly prepared in accordance with IFRS as adopted by the European Union; |
• | the Company financial statements have been properly prepared in accordance with FRS 101 Reduced Disclosure Framework issued by the UK’s Financial Reporting Council; and |
• | the Group and Company financial statements have been properly prepared in accordance with the requirements of the Companies Act 2014. |
• | Obtaining an understanding of management’s process to prepare cash flow forecasts for the going concern model. |
• | Evaluating the reliability of the underlying data (incorporating financing commitments) used to build the model. |
• | Performing analytical reviews on Operating, Investing and Financing Cashflows within the forecast period to actual results realised. |
• | Engaging a Modelling Specialist to review the integrity of key risk areas identified in the model. |
• | Reading underlying agreements relevant to management’s cash flow initiatives to evaluate the conditions set forth in the agreements that must be complied with by the Group and assessing the Group’s ability to meet these conditions during the going concern assessment period based on forecast performance. |
• | Meeting with Orion Infrastructure Partners (OIC) regarding historic and ongoing funding support. |
• | Performing sensitivity analysis on management’s forecasts. |
• | Assessing covenant compliance for a 12-month forward period from the expected signing of the consolidated financial statements. |
• | Assessing the appropriateness of the going concern disclosures in the notes to the consolidated financial statements. |
• | Assessing events which have occurred subsequent to year-end to consider the impact of these events. |
• | Inquiring with the directors and other management as to the Group and Company’s policies and procedures regarding compliance with laws and regulations, identifying, evaluating and accounting for litigation and claims, as well as whether they have knowledge of non-compliance or instances of litigation or claims. |
• | Inquiring of directors and inspection of policy documentation as to the Group and Company’s high-level policies and procedures to prevent and detect fraud, as well as whether they have knowledge of any actual, suspected or alleged fraud. |
• | Inquiring of directors regarding their assessment of the risk that the financial statements may be materially misstated due to irregularities, including fraud. |
• | Reading Board, audit committee and remuneration committee minutes. |
• | Considering remuneration incentive schemes and performance targets for management. |
• | Performing planning analytical procedures to identify any unusual or unexpected relationships. |
• | Identifying journal entries to test based on risk criteria and comparing the identified entries to supporting documentation. |
• | Evaluating the business purpose of significant unusual transactions. |
• | Assessing significant accounting estimates for bias. |
• | Assessing the disclosures in the financial statements. |
The key audit matter | How the matter was addressed in our audit | ||||
The Group has one cash generating unit which has been identified as the Group's wheel manufacturing operations in Australia. The Group performed an impairment assessment at year-end due to the the low market value of the Group and the continued loss making position. There is a significant risk of error relating to the valuation of the assets in the cash generating unit because the determination of whether an impairment exists and the amount of any loss requires the exercise of significant judgement relating to the future cashflows of these projects. For the reasons outlined above the engagement team determine this matter to be a key audit matter. | Our audit procedures included • Challenging the existence and completeness of impairment indicators, understanding the impact on the use and value of assets. • Testing valuation model and underlying key assumptions, reasonableness of valuation methodology and data inputs, including: • Evaluating management’s identification of Cash Generating Units (CGUs); • Evaluating the reliability of cash flow forecasts by performing a retrospective review of the prior year cash flow forecasts and post year end cash flow forecasts and comparing to the actual cash flows generated during the current year and subsequent to period end respectively, and to the relevant support including internal and external evidence available. • Performing sensitivity analysis on the future cash flows, growth and discount rates. • Due to the judgement involved, specialists were engaged to assist in determining the reasonableness of the discount rate and the long-term growth rate used in the value in use models. • Assess the appropriateness of the disclosures in the consolidated financial statements.. Based on evidence obtained, we found that the key assumptions used in the calculations of the value in use were within a reasonable range and supported the impairment recognised of $103m and the related disclosures in respect of the impairment to be appropriate. | ||||
The key audit matter | How the matter was addressed in our audit | ||||
The investment in subsidiaries are carried in the Company’s financial statements at cost less any impairment. As the carrying value of the cash generating unit was separately subject to an impairment review as noted above, the carrying value of the investments in subsidiaries was considered to give rise to a risk of material misstatement. As mentioned above, due to the low market value of the company, the continued loss making position, impairments recorded in the cash generating unit and the materiality of the investments in the context of the Company financial statements, this was the area that had the greatest focus of our overall audit of the Company financial statements. For the reasons outlined above the engagement team determine this matter to be a key audit matter. | Our audit procedures included among other things: • Obtaining an understanding of managements process to the assessment of investments in subsidiaries for potential impairment; • Considering the audit work performed in the current year on the recoverability of the cash generating unit; and • Comparing the carrying value of the investments to the net assets of the subsidiaries. As a result of management’s impairment review, an impairment charge of $53m by the Company was recorded in the year ended 30 June 2024. Based on procedures we performed, we considered that the impairment of the investment in subsidiaries is reasonable. | ||||
• | we have not identified material misstatements in the directors’ report; |
• | in our opinion, the information given in the directors’ report is consistent with the financial statements; and |
• | in our opinion, those parts of the directors’ report specified for our review, which does not include sustainability reporting when required by Part 28 of the Companies Act 2014, have been prepared in accordance with the Companies Act 2014. |
Note | 2024 AU $’000 | 2023 AU $’000 | |||||||
Sale of wheels | 67,560 | 37,477 | |||||||
Engineering services | 2,569 | 530 | |||||||
Sale of tooling | 1,330 | 253 | |||||||
Revenue | 2.1 | 71,459 | 38,260 | ||||||
Cost of goods sold | 3.2.1 | (98,523) | (55,094) | ||||||
Impairment of assets | 3.5 | (83,745) | — | ||||||
Gross loss | (110,809) | (16,834) | |||||||
Other income | 2.2 | 2,148 | 3,096 | ||||||
Operational expenses | (3,782) | (2,997) | |||||||
Research and development expenses | 2.4 | (36,102) | (16,180) | ||||||
Administrative expenses | (18,084) | (14,566) | |||||||
Marketing expenses | (1,760) | (1,494) | |||||||
Capital raising transaction costs | 4.7 | (31,584) | (24,746) | ||||||
Finance costs | 2.4 | (30,100) | (5,502) | ||||||
Finance income | 2.6 | 8,990 | — | ||||||
Loss before income tax expense | (221,083) | (79,223) | |||||||
Income tax expense | 5.1 | — | — | ||||||
Loss for the year | (221,083) | (79,223) | |||||||
Other comprehensive income / (loss) | |||||||||
Items that may be reclassified subsequently to the Consolidated Statements of Profit or Loss and Other Comprehensive Income: | |||||||||
Foreign currency translation differences – foreign operations | 303 | (62) | |||||||
Other comprehensive income / (loss) | 303 | (62) | |||||||
Total comprehensive loss for the year | (220,780) | (79,285) | |||||||
Earnings per share | |||||||||
Basic (dollars) | 2.5 | $(117.61) | $(59.20) | ||||||
Diluted (dollars) | 2.5 | $(117.61) | $(59.20) | ||||||
Note | June 30, 2024 AU $’000 | June 30, 2023 AU $’000 | |||||||
Current assets | |||||||||
Other current assets | 2,193 | 378 | |||||||
Inventories | 3.2 | 28,836 | 22,173 | ||||||
Contract assets | 2.1 | 13,952 | 8,239 | ||||||
Receivables | 3.1 | 8,538 | 6,430 | ||||||
Restricted trust fund | 4.1.1 | 674 | 14,677 | ||||||
Cash and cash equivalents | 4.1 | 3,705 | 19,582 | ||||||
Total current assets | 57,898 | 71,479 | |||||||
Non-current assets | |||||||||
Restricted trust fund | 4.1.1 | 7,001 | — | ||||||
Property, plant and equipment | 3.3 | — | 62,638 | ||||||
Right-of-use assets | 3.4 | — | 7,446 | ||||||
Intangible assets | 3.5 | — | 16,774 | ||||||
Total non-current assets | 7,001 | 86,858 | |||||||
Total assets | 64,899 | 158,337 | |||||||
Current liabilities | |||||||||
Payables | 3.6 | 45,247 | 15,474 | ||||||
Borrowings | 4.2 | 14,013 | 13,829 | ||||||
Lease liability | 3.4 | 705 | 645 | ||||||
Contract liabilities | 2.1 | 1,102 | 748 | ||||||
Deferred income | 3.7 | 2,114 | 1,919 | ||||||
Provisions | 3.8 | 4,359 | 12,957 | ||||||
Total current liabilities | 67,540 | 45,572 | |||||||
Non-current liabilities | |||||||||
Borrowings | 4.2 | 140,853 | 70,833 | ||||||
Payables | 3.6 | 15,193 | — | ||||||
Derivative liability | 4.2 | 531 | — | ||||||
Lease liability | 3.4 | 7,061 | 7,368 | ||||||
Contract liabilities | 2.1 | 4,527 | 1,755 | ||||||
Deferred income | 3.7 | 13,323 | 15,235 | ||||||
Provisions | 3.8 | 2,834 | 1,843 | ||||||
Total non-current liabilities | 184,322 | 97,034 | |||||||
Total liabilities | 251,862 | 142,606 | |||||||
Net (liabilities) / assets | (186,963) | 15,731 | |||||||
Equity (Deficit) | |||||||||
Contributed equity | 4.4 | — | — | ||||||
Warrants | 7,504 | — | |||||||
Reserves | 4.6 | 1,990 | 7,166 | ||||||
Accumulated losses | (196,457) | 8,565 | |||||||
Total equity (deficit) | (186,963) | 15,731 | |||||||
![]() | ![]() | |||||
Dale McKee | Matti Masanovich | June 6, 2025 | ||||
Director | Director | |||||
Note | Share Capital* AU $’000 | Share Premium* AU $’000 | Warrants AU $’000 | Share buyback reserve AU $’000 | Share based payment reserve AU $’000 | Accumulated losses* AU $’000 | Foreign currency translation reserve AU $’000 | Total equity (deficit) AU $’000 | |||||||||||||||||||
Balance as of July 1, 2022 | — | — | — | (311) | 7,214 | 85,178 | (156) | 91,925 | |||||||||||||||||||
Loss after tax for the year | — | — | — | — | — | (79,223) | — | (79,223) | |||||||||||||||||||
Other comprehensive loss for the year | — | — | — | — | — | — | (62) | (62) | |||||||||||||||||||
Total comprehensive loss for the year | — | — | — | — | — | (79,223) | (62) | (79,285) | |||||||||||||||||||
Transactions with owners in their capacity as owners | |||||||||||||||||||||||||||
Share options exercised | 6.7 | — | — | — | — | 481 | 2,610 | — | 3,091 | ||||||||||||||||||
Total transactions with owners in their capacity as owners | — | — | — | — | 481 | 2,610 | — | 3,091 | |||||||||||||||||||
Balance as of June 30, 2023 | — | — | — | (311) | 7,695 | 8,565 | (218) | 15,731 | |||||||||||||||||||
Balance as of July 1, 2023 | — | — | — | (311) | 7,695 | 8,565 | (218) | 15,731 | |||||||||||||||||||
Loss after tax for the year | — | — | — | — | — | (221,083) | — | (221,083) | |||||||||||||||||||
Other comprehensive income for the year | — | — | — | — | — | — | 303 | 303 | |||||||||||||||||||
Total comprehensive income / (loss) for the year | — | — | — | — | — | (221,083) | 303 | (220,780) | |||||||||||||||||||
Transactions with owners in their capacity as owners | |||||||||||||||||||||||||||
Share options exercised | 6.7 | — | — | — | — | (886) | 886 | — | — | ||||||||||||||||||
Equity-settled share-based payment | — | — | — | — | (410) | — | — | (410) | |||||||||||||||||||
Cancellation of share-based payment plans | — | — | — | 311 | (4,802) | 4,491 | — | — | |||||||||||||||||||
Settlement of share-based payment with cash alternative | — | — | — | — | (1,597) | — | — | (1,597) | |||||||||||||||||||
Equity-settled share-based payment to non-employee | — | — | — | — | 1,905 | — | — | 1,905 | |||||||||||||||||||
Acquisition transaction | 6.7 | — | 10,684 | — | — | — | — | — | 10,684 | ||||||||||||||||||
Capital reduction | 6.7 | — | (10,684) | — | — | — | 10,684 | — | — | ||||||||||||||||||
Issue of warrants | — | — | 7,504 | — | — | — | — | 7,504 | |||||||||||||||||||
Total transactions with owners in their capacity as owners | — | — | 7,504 | 311 | (5,790) | 16,061 | — | 18,086 | |||||||||||||||||||
Balance as of June 30, 2024 | — | — | 7,504 | — | 1,905 | (196,457) | 85 | (186,963) | |||||||||||||||||||
* | Comparative periods have been re-stated with the capital structure of Carbon Revolution PLC being the continuing legal parent. Refer to note 6.7. |
Note | 2024 AU $’000 | 2023 AU $’000 | |||||||
Cash flow from operating activities | |||||||||
Receipts from customers | 66,724 | 45,742 | |||||||
Receipt of grants and research and development incentives | 202 | 15,446 | |||||||
Payments to suppliers and employees | (114,049) | (80,215) | |||||||
Interest received | 202 | 61 | |||||||
Capital raising transaction costs | (11,712) | (9,030) | |||||||
Borrowing costs | (9,025) | (20,676) | |||||||
Finance costs | (9,187) | (3,810) | |||||||
Net cash used in operating activities | 4.1.2 | (76,845) | (52,482) | ||||||
Cash flow from investing activities | |||||||||
Payments for property, plant and equipment | (19,632) | (13,082) | |||||||
Payments for intangible assets | (5,446) | (4,874) | |||||||
Sale proceeds from sale of property, plant and equipment | 2 | 3 | |||||||
Net cash used in investing activities | (25,076) | (17,953) | |||||||
Cash flow from financing activities | |||||||||
Proceeds from third party borrowings | 107,953 | 124,963 | |||||||
Repayment of third-party borrowings | (30,512) | (43,212) | |||||||
Reclassification (to)/from restricted trust fund | 4.1.1 | 7,002 | (14,677) | ||||||
Capital raising transaction costs | — | — | |||||||
Proceeds from capital reorganization | 6.7 | 1,085 | — | ||||||
Repayment of lease liability | (418) | (604) | |||||||
Net cash provided by financing activities | 85,110 | 66,470 | |||||||
Net decrease in cash and cash equivalents held | (16,811) | (3,965) | |||||||
Cash and cash equivalents at beginning of financial year | 19,582 | 22,693 | |||||||
Effects of exchange rate changes on cash and cash equivalents | 934 | 854 | |||||||
Cash and cash equivalents at end of financial year | 3,705 | 19,582 | |||||||
Basis of preparation |
1.1 | Corporate information |
1.2 | Basis of preparation |
1.3 | Going concern |
• | Ongoing support from PIUS and OIC of US$11.4 million (A$17.4 million), including: |
• | conditional access to US$5 million (A$7.6 million) of capital under the OIC financing arrangements (as per Notes 4 and 6); |
• | conditional access to US$0.4 million (A$0.7 million) of capital under the PIUS financing arrangement (as per Notes 4 and 6); |
• | moving from cash paid interest to Payment in Kind (“PIK”) interest from July 2025 to December 2025, which is worth approximately US$6m (A$9.1 million) |
• | OIC also has US$15million (A$22.7 million) of further funds available for investment in the Group, currently earmarked for future expansion opportunities. If the Group did require near term assistance after exhausting all other reasonable sources of liquidity, OIC may repurpose these funds to support the Group’s short-term liquidity needs, subject to OIC’s approval at the time. |
• | Its unrestricted cash balance of A$ 1.5 million at April 30, 2025; |
• | Access to capital through the issuance of debt or equity securities via public or private placement; and |
• | Access to capital under the Committed Equity Facility (“CEF”). |
• | Satisfying the conditions necessary to access the remaining US$5 million (A$7.6 million) of OIC funds and US$0.4 million (A$0.7 million) PIUS funds, along with moving from cash interest to PIK interest in the second half of CY25; |
• | Achieving forecast production levels, sales mix and pricing; |
• | Reducing unit costs, reducing fixed overheads and limiting non-contracted capital expenditures in accordance with cost reduction initiatives; |
• | Securing agreement for ongoing deferral of previously agreed transaction costs deferrals from the capital reorganization (as per Note 3.6.1) amounting to a total of US$15.0 million (A$22.5 million). Under an agreement the Group had reached with these creditors to delay payment, US$5 million (A$7.6 million) was payable in November 2024, with the remainder to be paid from the proceeds of certain fundraising transactions or on a straight line basis over 5 years (depending on the option selected by the supplier). The US$5 million (A$7.6 million) payment was not made in November 2024 and a further US$10.0 million (A$15.0 million) is now payable or payable in twelve months from signing date, unless the relevant suppliers agree to or accept further deferral of the transaction costs for at least twelve months from signing date and until sufficient cashflow can be generated from operations or alternative sources of funding are obtained to pay down these debts; |
• | Ongoing support from suppliers and customers in the form of favourable payment terms and bailment arrangements; |
• | Successful outcome of claims which the Group has made or plans to make against customers primarily associated with ordered volumes that are below the volumes which the Group was required to build and reserve capacity for under its customer contracts, and cancellation of a wheel program; and |
• | Raising capital to fund operations through the issuance of debt or equity securities via public or private placement (including through the CEF). |
1.4 | Basis of consolidation |
• | assets and liabilities are translated at the closing rate at the reporting date; and |
• | income and expenses are translated at average exchange rates throughout the course of the year (unless this is not a reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income and expenses are translated at the rates on the dates of the transactions); and |
• | all resulting exchange differences are recognized in other comprehensive income and accumulated in the foreign currency translation reserve, a separate component of equity. |
1.5 | Significant accounting judgements, estimates and assumptions |
Note 3.2 Inventories | Note 3.5 Intangible assets | ||
Note 3.3 Property, plant and equipment | Note 3.7 Deferred income | ||
1.6 | Sales Taxes |
1. | Revenues, expenses and assets are recognized net of the amount of associated GST, unless the GST incurred is not recoverable from the Australian taxation authority; |
2. | Receivables and payables are stated inclusive of the amount of GST receivable or payable; |
3. | The net amount of GST recoverable from, or payable to, the Australian taxation authority is included with other receivables or payables in the Consolidated Statements of Financial Position; |
4. | Cash flows are presented on a gross basis. The GST components of cash flows arising from investing and financing activities are presented as operating cash flows; and |
5. | Commitments are disclosed net of GST. |
6. | The Company did not incur material VAT amounts as it did not undertake any trading in Ireland during FY24. |
7. | The Company did not incur material sales tax amounts as it did not undertake any trading in United States during FY24. |
1.7 | Reclassification |
2 | Operating performance |
2.1 | Revenue from contracts with customers |
Disaggregation of revenue | 2024 $’000 | 2023 $’000 | ||||
External revenue by product lines | ||||||
Sale of wheels | 67,560 | 37,477 | ||||
Engineering services | 2,569 | 530 | ||||
Sale of tooling | 1,330 | 253 | ||||
Total Revenue | 71,459 | 38,260 | ||||
2024 $’000 | 2023 $’000 | |||||
External revenue by timing of revenue | ||||||
Goods transferred at a point in time | 12,307 | 18,885 | ||||
Goods transferred over time | 55,253 | 18,592 | ||||
Services transferred at a point in time - tooling | 1,330 | 253 | ||||
Services transferred over time | ||||||
- Engineering | 2,569 | 530 | ||||
- Tooling | — | — | ||||
Total revenue | 71,459 | 38,260 | ||||
2024 $’000 | 2023 $’000 | |||||
Contract Assets | ||||||
Opening balance | 8,239 | 5,909 | ||||
Additions | 50,849 | 24,821 | ||||
Utilization of prepayment | 15,921 | — | ||||
Advance payments | (30,212) | (13,064) | ||||
Transfer to trade receivables | (30,845) | (9,427) | ||||
Total contract assets | 13,952 | 8,239 | ||||
2024 $’000 | 2023 $’000 | |||||
Contract liabilities | ||||||
Opening balance | 2,503 | 781 | ||||
Additions | 7,025 | 2,505 | ||||
Revenue recognized | (3,899) | (783) | ||||
Total Contract liabilities | 5,629 | 2,503 | ||||
Contract liability – current | 1,102 | 748 | ||||
Contract liability – non current | 4,527 | 1,755 | ||||
Total contract liabilities | 5,629 | 2,503 | ||||
2.2 | Other income |
2024 $’000 | 2023 $’000 | |||||
Government grants | 1,936 | 2,777 | ||||
Interest income* | — | 61 | ||||
Unrealized foreign exchange gain* | — | — | ||||
Other income | 212 | 258 | ||||
Total other income | 2,148 | 3,096 | ||||
* | Unrealized foreign exchange gain and Interest income for the year ended June 30, 2024 has been classified in finance income. The comparative period disclosure has not been restated as the amounts are immaterial (Unrealized foreign exchange loss was classified as administrative expenses: 2023: $$0.5 million, Unrealized foreign exchange gain: 2022: $0.5 million; Interest income: 2023: $0.1 million, 2022: $0.1 million). |
2.2.1 | Information about revenue and other income |
• | the customer simultaneously receives and consumes the benefits provided by Carbon Revolution; |
• | Carbon Revolution’s performance creates or enhances an asset that the customer controls as Carbon Revolution performs; or |
• | Carbon Revolution’s performance does not create an asset with an alternative use to Carbon Revolution and Carbon Revolution has an enforceable right to payment for performance completed to date. |
2.3 | Segments |
2024 $’000 | 2023* $’000 | |||||
Revenue | ||||||
Ireland | — | — | ||||
Australia | 71,459 | 38,260 | ||||
71,459 | 38,260 | |||||
Non-current assets | ||||||
Ireland | — | — | ||||
Australia | 7,001 | 86,858 | ||||
7,001 | 86,858 | |||||
* | Prior periods were reclassified to reflect the current presentation as a result of Carbon Revolution PLC becoming the legal parent of the Group in 2024. More details see the Transaction described in note 6.7. |
2.4 | Expenses by nature |
Finance costs | 2024 $’000 | 2023 $’000 | ||||
Cash interest on third party borrowings | 9,187 | 2,676 | ||||
Interest on lease liabilities | 291 | 297 | ||||
Effective interest on third party borrowings | 16,032 | 1,448 | ||||
Loss on modification | 882 | — | ||||
Loss on extinguishment | 2,084 | — | ||||
Supplier financing costs | 954 | 446 | ||||
Finance costs | 2024 $’000 | 2023 $’000 | ||||
Interest other | 606 | 635 | ||||
Realized foreign exchange loss* | 64 | — | ||||
30,100 | 5,502 | |||||
Salaries and employee benefit expense | ||||||
Wages and salaries | 53,224 | 39,023 | ||||
Post-employment benefits (defined contribution plans) | 4,464 | 3,379 | ||||
Share based payments expense | (196) | 3,091 | ||||
57,492 | 45,493 | |||||
Depreciation and amortization | ||||||
Property, plant and equipment | 9,089 | 7,382 | ||||
Right of use assets | 742 | 695 | ||||
Capitalized development costs | 3,312 | 2,376 | ||||
Patents and trademarks | 75 | 89 | ||||
13,218 | 10,542 | |||||
Research and development expense | ||||||
Research and development** | 16,951 | 16,180 | ||||
Impairment and write-offs of intangible assets | 19,151 | — | ||||
36,102 | 16,180 | |||||
* | Realized foreign exchange loss for the year ended June 30, 2024 has been classified in finance costs. The comparative period disclosure has not been restated as the amounts are immaterial (Realized foreign exchange gain 2023: $0.2 million, Realized foreign exchange loss: 2022: $0.1 million). The amounts were recognized in other income and administrative expenses respectively in comparative periods. |
** | Research and development included amortization of capitalised research and development expenses and wages and salaries of employees in research and development function. |
2.4.1 | Information about expenses |
Class of fixed asset | Depreciation period | Depreciation method | ||||
Leasehold improvements | Shorter of 20 years or the remaining term of the lease | Straight line | ||||
Manufacturing equipment | 4 to 20 years (2023: 2 to 10 years) | Straight line (2023: diminishing value) | ||||
Tooling | 5 to 10 years (2023: 3 to 10 years) | Straight line (2023: diminishing value) | ||||
Other equipment | 3 to 20 years (2023: 3 to 5 years) | Straight line (2023: diminishing value) | ||||
(i) | purchases of supplies and materials used in our research and development projects, |
(ii) | salaries, bonuses and related expenses for personnel engaged in research and development, |
(iii) | consumption of low-value consumables used in our research and development projects, |
(iv) | depreciation of property, plant and equipment used in connection with our research and development efforts, and |
(v) | amortization of capitalized development costs. |
2.5 | Earnings per share |
2024 $’000 | 2023 $’000 | |||||
The following reflects the income used in the basic and diluted earnings per share computations: | ||||||
a) Earnings used in calculating earnings per share | ||||||
Earnings/(loss) for the purposes of basic earnings per share being loss for the year | (221,083) | (79,223) | ||||
Effect of dilutive potential ordinary shares | — | — | ||||
Earnings/(loss) for the purposes of diluted earnings per share | (221,083) | (79,223) | ||||
No.’000 | No.’000 | |||||
b) Weighted average number of shares | ||||||
No.’000 | No.’000 | |||||
Weighted average number of ordinary shares for the purposes of basic earnings per share* | 1,880 | 1,338 | ||||
Effect of dilutive potential ordinary shares | — | — | ||||
Loss per share | ||||||
Basic (dollars) | $(117.61) | $(59.20) | ||||
Diluted (dollars) | $(117.61) | $(59.20) | ||||
* | The comparative periods were restated by the exchange ratio of 0.00642 as established in the Transaction as described in Note 6.7. The exchange ratio was applied to the number of shares to calculate the adjusted weighted average shares. |
2.6 | Finance Income |
2024 $’000 | 2023 $’000 | |||||
Gain on remeasurement of warrant liabilities | 6,687 | — | ||||
Unrealized foreign exchange gain* | 2,101 | — | ||||
Interest income* | 202 | — | ||||
Total finance income | 8,990 | — | ||||
* | Unrealized foreign exchange gain and Interest income for the year ended June 30, 2024 has been classified in finance income unless otherwise stated. The comparative period disclosure has not been restated as the amounts are immaterial (Unrealized foreign exchange loss was classified as administrative expenses: 2023: $0.5 million, Unrealized foreign exchange gain was classified as other income 2022: $0.5 million; Interest income was classified as other income 2023: $0.1 million, 2022: $0.1 million). |
3 | Operating assets and liabilities |
3.1 | Receivables |
2024 $’000 | 2023 $’000 | |||||
Trade receivables | ||||||
Not past due | 4,622 | 4,220 | ||||
Past due 1 – 30 days | 837 | 623 | ||||
Past due 31 – 90 days | 1,623 | 443 | ||||
Past due 90 days and over | 681 | 216 | ||||
7,763 | 5,502 | |||||
Allowance for impairment losses | (565) | (119) | ||||
Trade receivables | 7,198 | 5,383 | ||||
Apprenticeship grant funding | 294 | 25 | ||||
Other receivables | 11 | 267 | ||||
GST recoverable | 1,035 | 755 | ||||
Trade and other receivables | 8,538 | 6,430 | ||||
3.1.1 | Information about receivables |
3.2 | Inventories |
2024 $’000 | 2023 $’000 | |||||
Current | ||||||
Raw materials | 19,654 | 13,301 | ||||
Work in progress | 7,566 | 5,772 | ||||
Finished goods | 2,922 | 3,649 | ||||
Consumables and spare parts | 2,984 | 2,560 | ||||
Provision for trial wheels, obsolescence and scrap | (4,290) | (3,109) | ||||
Inventories at the lower of cost and net realizable value | 28,836 | 22,173 | ||||
3.2.1 | Information about inventories and significant estimates |
• | Raw materials – recorded at standard cost, reassessed against actual costs quarterly. |
• | Finished goods and work-in-progress – cost of direct materials, labor, outsourced processing costs and a proportion of manufacturing overheads based on normal operating capacity but excluding finance costs. |
• | Consumables and spare parts – recorded at purchase price. Consumables and spares are assessed for ongoing usefulness and written off if they are no longer likely to be of use. |
3.3 | Property, plant and equipment |
Capital works in progress $’000 | Leasehold improvements $’000 | Manufacturing equipment $’000 | Tooling $’000 | Other equipment $’000 | Total $’000 | |||||||||||||
Gross cost | 17,095 | 5,839 | 52,640 | 16,034 | 2,960 | 94,568 | ||||||||||||
Less accumulated depreciation | — | (1,642) | (18,467) | (9,964) | (1,857) | (31,930) | ||||||||||||
At June 30, 2023 | 17,095 | 4,197 | 34,173 | 6,070 | 1,103 | 62,638 | ||||||||||||
Gross cost | 21,569 | 5,839 | 69,671 | 16,984 | 3,074 | 117,137 | ||||||||||||
Less accumulated depreciation | — | (2,305) | (23,442) | (12,332) | (2,436) | (40,515) | ||||||||||||
Less Impairment | (21,569) | (3,534) | (46,229) | (4,652) | (638) | (76,622) | ||||||||||||
At June 30, 2024 | — | — | — | — | — | — | ||||||||||||
Movement in carrying amounts | ||||||||||||||||||
Balance at June 30, 2022 | 18,950 | 4,294 | 26,384 | 6,708 | 1,280 | 57,616 | ||||||||||||
Additions | 11,478 | — | — | — | — | 11,478 | ||||||||||||
Transfer of maintenance spares | — | — | 953 | — | — | 953 | ||||||||||||
Transfer into/ (out of) capital WIP | (13,306) | 189 | 11,233 | 1,709 | 175 | — | ||||||||||||
Depreciation expense | — | (286) | (4,397) | (2,347) | (352) | (7,382) | ||||||||||||
Write-offs | (27) | — | — | — | — | (27) | ||||||||||||
Balance at June 30, 2023 | 17,095 | 4,197 | 34,173 | 6,070 | 1,103 | 62,638 | ||||||||||||
Additions | 24,476 | — | — | — | — | 24,476 | ||||||||||||
Transfer into/ (out of) capital WIP | (18,841) | — | 17,113 | 1,580 | 148 | — | ||||||||||||
Depreciation expense | — | (663) | (4,994) | (2,843) | (589) | (9,089) | ||||||||||||
Transfer to inventories | (943) | — | — | — | — | (943) | ||||||||||||
Impairment and write-offs | (21,890) | (3,534) | (46,282) | (4,807) | (662) | (77,175) | ||||||||||||
Transfer from intangible assets | 103 | — | — | — | — | 103 | ||||||||||||
Disposals | — | — | (10) | — | — | (10) | ||||||||||||
Balance at June 30, 2024 | — | — | — | — | — | — | ||||||||||||
3.4 | Leases |
Right-of-use assets | 2024 $’000 | 2023 $’000 | ||||
Cost at start of year | 10,440 | 9,863 | ||||
Remeasurement | 419 | 577 | ||||
Closing balance at end of year | 10,859 | 10,440 | ||||
Accumulated depreciation at start of year | (2,994) | (2,299) | ||||
Depreciation charge for the year | (742) | (695) | ||||
Closing balance at end of year | (3,736) | (2,994) | ||||
Impairment | (7,123) | — | ||||
Carrying amount | — | 7,446 | ||||
Lease liability | ||||||
Current | 705 | 645 | ||||
Non-current | 7,061 | 7,368 | ||||
7,766 | 8,013 | |||||
2024 $’000 | 2023 $’000 | |||||
Depreciation charge of right of use assets | ||||||
Property | 742 | 695 | ||||
Interest expense | 291 | 297 | ||||
Impairment of assets (included under cost of goods sold) | 7,123 | — | ||||
Expense relating to short-term leases (included in costs of goods sold and administrative expenses) | 407 | 181 | ||||
3.4.1 | Information about leases and significant estimates |
3.5 | Intangible assets |
Development costs $’000 | Patents and trademarks $’000 | Total $’000 | |||||||
Gross cost | 20,442 | 1,537 | 21,979 | ||||||
Less accumulated amortization | (4,623) | (582) | (5,205) | ||||||
At June 30, 2023 | 15,819 | 955 | 16,774 | ||||||
Gross cost | 25,530 | 1,591 | 27,121 | ||||||
Less accumulated amortization | (7,610) | (657) | (8,267) | ||||||
Impairment | (17,920) | (934) | (18,854) | ||||||
At June 30, 2024 | — | — | — | ||||||
Movement in carrying amounts | |||||||||
Balance at July 1, 2022 | 13,503 | 861 | 14,364 | ||||||
Additions | 4,691 | 183 | 4,874 | ||||||
Amortization | (2,375) | (89) | (2,464) | ||||||
Balance at June 30, 2023 | 15,819 | 955 | 16,774 | ||||||
Additions | 5,813 | 54 | 5,867 | ||||||
Impairment and write offs | (18,217) | (934) | (19,151) | ||||||
Transfer to PP&E | (103) | — | (103) | ||||||
Amortization expense | (3,312) | (75) | (3,387) | ||||||
Balance at June 30, 2024 | — | — | — | ||||||
3.5.1 | Information about intangible assets and significant estimates |
- | the technical feasibility of completing the intangible asset so that it will be available for use or sale; |
- | the intention to complete the intangible asset and use or sell it; |
- | the ability to use or sell the intangible asset; |
- | how the intangible asset will generate probable future economic benefits; |
- | the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and |
- | the ability to measure the expenditure attributable to the intangible asset during the development phase. |
3.5.2 | Impairment to the CGU |
30 June 2024 | CGU $’000 | Note reference | ||||
Property, plant and equipment | 76,622 | 3.3 | ||||
Right-of-use assets | 7,123 | 3.4 | ||||
Intangible assets | 18,854 | 3.5 | ||||
Impairment of assets under IAS 36 | 102,599 | |||||
30 June 2024 | CGU $’000 | Note reference | ||||
Working capital | 889 | |||||
Lease liability | (7,766) | 3.4 | ||||
CGU carrying amount | 95,722 | |||||
Recoverable amount | — | |||||
Impairment loss | 102,599 | |||||
30 June 2024 | |||
Pre-tax discount rate | 21.4% | ||
Post-tax discount rate | 15.0% | ||
Terminal growth rate beyond 5 years | 1.0% | ||
3.6 | Payables |
2024 $’000 | 2023 $’000 | |||||
Current Unsecured liabilities | ||||||
Trade payables | 27,530 | 3,828 | ||||
Deferred transaction costs | 7,745 | — | ||||
Accruals | 7,974 | 10,836 | ||||
Interest accrued | 473 | 427 | ||||
Other payables | 1,525 | 383 | ||||
45,247 | 15,474 | |||||
Non-current Unsecured liabilities | ||||||
Deferred transaction costs | 15,193 | — | ||||
15,193 | — | |||||
3.6.1 | Information about payables |
3.7 | Deferred income |
Deferred income – government grants | 2024 $’000 | 2023 $’000 | ||||
Balance as of July 1 | 17,154 | 6,239 | ||||
Received during the year | 219 | 13,000 | ||||
Released to the Consolidated Statements of Profit or Loss and Other Comprehensive Income | (1,936) | (2,085) | ||||
Balance as of June 30 | 15,437 | 17,154 | ||||
Current | 2,114 | 1,919 | ||||
Non-current | 13,323 | 15,235 | ||||
15,437 | 17,154 | |||||
3.8 | Provisions |
Employee benefits $’000 | Make good Provision $’000 | Warranty claims $’000 | Transaction costs $’000 | Total $’000 | |||||||||||
Current | 2,903 | — | 595 | 9,459 | 12,957 | ||||||||||
Non-current | 531 | 247 | 1,065 | — | 1,843 | ||||||||||
At June 30, 2023 | 3,434 | 247 | 1,660 | 9,459 | 14,800 | ||||||||||
Employee benefits $’000 | Make good provision $’000 | Warranty claims $’000 | Transaction costs $’000 | Total $’000 | |||||||||||
Current | 3,754 | — | 605 | — | 4,359 | ||||||||||
Non-current | 743 | 262 | 1,829 | — | 2,834 | ||||||||||
At June 30, 2024 | 4,497 | 262 | 2,434 | — | 7,193 | ||||||||||
Make good provision $’000 | Warranty claims $’000 | Transaction costs $’000 | Total $’000 | |||||||||
Movement in carrying amounts | ||||||||||||
Balance at July 1, 2022 | 234 | 1,495 | — | 1,729 | ||||||||
Provided for during the year | 13 | 165 | 9,459 | 9,637 | ||||||||
Balance at June 30, 2023 | 247 | 1,660 | 9,459 | 11,366 | ||||||||
Provided for during the year | 15 | 814 | — | 829 | ||||||||
Paid during the year | — | (40) | — | (40) | ||||||||
(Transferred) to payables during the year | — | — | (9,459) | (9,459) | ||||||||
Balance at June 30, 2024 | 262 | 2,434 | — | 2,696 | ||||||||
3.8.1 | Information about individual provisions and significant estimates |
4 | Capital structure and financing |
4.1 | Cash and cash equivalents, Restricted trust fund |
2024 $’000 | 2023 $’000 | |||||
Current assets | ||||||
Cash at bank and in hand | 3,705 | 19,582 | ||||
Cash and cash equivalents in the Consolidated Statements of Financial Position and Consolidated Statements of Cash Flows | 3,705 | 19,582 | ||||
4.1.1 | Restricted trust fund |
4.1.2 | Notes to the Consolidated Statements of Cash Flows |
2024 $’000 | 2023 $’000 | |||||
Loss after income tax | (221,083) | (79,223) | ||||
Non-cash items from ordinary activities | ||||||
Depreciation and amortization | 13,218 | 10,543 | ||||
Share based payment expenses | (196) | 3,091 | ||||
Loss on sale of plant and equipment | 8 | 2 | ||||
Movement in inventory provision | 1,181 | (1,656) | ||||
Impairment and write-offs of property, plant and equipment | 77,175 | — | ||||
Impairment and write-offs of intangible assets | 19,151 | — | ||||
Impairment of right of use asset | 7,123 | — | ||||
Financing activity in prior financial year | — | — | ||||
Unrealized foreign exchange on borrowings | (2,500) | — | ||||
Non-cash borrowing costs | 16,711 | — | ||||
Listing expenses | 24,679 | — | ||||
(Gain)/Loss on revaluation of financial instruments | (6,687) | — | ||||
Loss on USD term loan modification | 2,966 | — | ||||
Other borrowing costs | — | (20,676) | ||||
Changes in assets and liabilities | ||||||
(Increase)/decrease in assets: | ||||||
- Receivables | (2,108) | 8,053 | ||||
- Contract assets | (5,713) | (2,330) | ||||
- Inventories | (7,844) | (1,306) | ||||
- Other assets | (1,815) | 1,209 | ||||
2024 $’000 | 2023 $’000 | |||||
Increase/(decrease) in liabilities: | ||||||
- Payables | 15,087 | 7,247 | ||||
- Contract liabilities | 3,126 | 1,722 | ||||
- Deferred income | (1,717) | 10,915 | ||||
- Provisions | (7,607) | 9,927 | ||||
Cash used in operating activities | (76,845) | (52,482) | ||||
4.1.3 | Notes to the Consolidated Statements of Cash Flows |
2024 | Cash changes | Non-cash changes | Cash changes | ||||||||||||||||||
Note | July 1, 2023 $’000 | Financing cash flows (i) $’000 | Lease remeasurement $’000 | Other changes (ii) $’000 | Interest paid (iv) $’000 | June 30, 2024 $’000 | |||||||||||||||
Current borrowings at amortized cost | |||||||||||||||||||||
Unsecured | |||||||||||||||||||||
Term loan with customer | 4.2 | 4,523 | (4,523) | — | 529 | (529) | — | ||||||||||||||
Supplier finance arrangement | 4.2 | 9,306 | 4,707 | — | 451 | (451) | 14,013 | ||||||||||||||
Non-current borrowings at amortized cost | |||||||||||||||||||||
Secured | |||||||||||||||||||||
USD term loan | 4.2 | 70,833 | (83) | — | 15,539 | (7,821) | 78,468 | ||||||||||||||
OIC Series 2024-A notes (USD) | 4.2 | — | 13,952 | — | (2,977) | (37) | 10,938 | ||||||||||||||
Unsecured | |||||||||||||||||||||
OIC Class A preferred shares (USD) | 4.2 | — | 48,326 | — | (1,949) | — | 46,377 | ||||||||||||||
OIC Class B preferred shares (USD) | 4.2 | — | 6,037 | — | (967) | — | 5,070 | ||||||||||||||
Derivative Liability | |||||||||||||||||||||
Derivative liability | 4.2 | — | — | — | 531 | — | 531 | ||||||||||||||
Lease liabilities | |||||||||||||||||||||
Lease liabilities | 3.4 | 8,013 | (418) | 418 | (52) | (195) | 7,766 | ||||||||||||||
92,675 | 67,998 | 418 | 11,105 | (9,033) | 163,163 | ||||||||||||||||
2023 | Cash changes | Non-cash changes | Cash changes | ||||||||||||||||||
Note | July 1, 2022 $’000 | Financing cash flows (i) $’000 | Lease remeasurement $’000 | Other changes (ii) $’000 | Interest paid (iv) $’000 | June 30, 2023 $’000 | |||||||||||||||
Current borrowings at amortized cost | |||||||||||||||||||||
Secured | |||||||||||||||||||||
Working capital facility | 6,843 | (6,843) | — | 320 | (320) | — | |||||||||||||||
Term loan | 2,889 | (2,889) | — | 830 | (830) | — | |||||||||||||||
Letter of credit facility | 4,000 | (4,000) | — | 64 | (64) | — | |||||||||||||||
Unsecured | |||||||||||||||||||||
Term loan with customer | 4.2 | — | 4,523 | — | 111 | (111) | 4,523 | ||||||||||||||
Supplier finance arrangement | 4.2 | 4,954 | 4,352 | — | 446 | (446) | 9,306 | ||||||||||||||
Non-current borrowings at amortized cost | |||||||||||||||||||||
Unsecured | |||||||||||||||||||||
Term loan | 4,333 | (4,333) | — | — | — | — | |||||||||||||||
Term loan (USD) (iii) | 4.2 | — | 70,265 | — | 2,194 | (1,626) | 70,833 | ||||||||||||||
Lease liabilities | 3.4 | 8,040 | (604) | 577 | 297 | (297) | 8,013 | ||||||||||||||
31,059 | 60,471 | 577 | 4,262 | (3,694) | 92,675 | ||||||||||||||||
(i) | Cash flows from borrowings make up the net amount of proceeds from borrowings, repayments of borrowings and borrowing costs in the Consolidated Statements of Cash Flows. |
(ii) | Other changes include interest accruals and foreign exchange movements and amendments to existing loan arrangements. |
(iii) | Amount is net of $20.7 million loan establishment cost presented within operating cash flows. Refer to Note 4.2. |
(iv) | Cash flows from interest paid are included in Finance costs under Cash flow from operating activities in the Consolidated Statements of Cash Flows. |
4.2 | Borrowings and other financial liabilities |
Interest rate % | Maturity | 2024 $’000 | 2023 $’000 | |||||||||
Current borrowings and other financial liabilities | ||||||||||||
Unsecured | ||||||||||||
Term loan with customer | 10.0% | June 2024 | — | 4,523 | ||||||||
Supplier finance arrangement | 6% + RBA cash rate | June 2025 | 14,013 | 9,306 | ||||||||
Current Borrowings | 14,013 | 13,829 | ||||||||||
Lease liabilities | 705 | 645 | ||||||||||
14,718 | 14,474 | |||||||||||
Interest rate % | Maturity | 2024 $’000 | 2023 $’000 | |||||||||
Non-current borrowings and other financial liabilities | ||||||||||||
Unsecured | ||||||||||||
OIC Class A preferred shares (USD) | 12.00% | November 2028 | 46,377 | — | ||||||||
USD term loan | 12.00% | May 2027 | 78,468 | 70,833 | ||||||||
OIC Series 2024-A notes (USD) | 12.00% | May 2027 | 10,938 | — | ||||||||
OIC Class B preferred shares (USD) | 12.00% | November 2028 | 5,070 | — | ||||||||
Non-current borrowings | 140,853 | 70,833 | ||||||||||
Derivative liabilities - Warrants | 531 | — | ||||||||||
Lease liabilities | 7,061 | 7,368 | ||||||||||
148,445 | 78,201 | |||||||||||
• | Interest only until May 2026 inclusive, and thereafter monthly principal repayments of US$2 million along with interest until maturity in May 2027; |
• | Interest payable at 8.5% pa coupon plus an additional 3.5% accumulating paid-in-kind interest; |
• | 3% amendment fee due as an exit premium (US1.8 million) payable at maturity; and |
• | The term loan now ranks equally with the Series 2024-A Notes issued to OIC |
• | the qualitative factors surrounding the modification and the fact that despite the USD term loan now ranking equal to the Series 2024-A Notes the insurance arrangement is still in place resulting in a non-substantial modification conclusion; and |
• | The qualitative and quantitative impacts of the changes, including the difference in cash flows arising from the change in terms using the original effective interest rate of the loan to be not substantial (less than 10% as the changes in interest rates and incremental amendment fee offset changes in the timing of repayments) i.e. also not substantially different. |
• | OIC subscribed for and purchased from the Company Class A redeemable preferred shares with a 12% fixed accumulating distribution (the “Preferred Shares”) and warrants (“SEF Warrants”) for aggregate gross proceeds of US$35 million (equivalent to AUD$54.7 million) less transaction costs. |
• | The Class A preference shares are recognized as a financial liability at amortized cost as they must be redeemed by November 2028. The Company may elect to redeem Class A preferred shares on issue at an earlier date at its discretion subject to a return to the holder the greater of (i) a 1.75x Multiple on Invested Capital (“MOIC”) return on face value, or (ii) a 12% IRR. |
• | The SEF warrants carry a US$0.01 strike price and entitle OIC to up to a maximum 19.99% of the fully diluted Company shares on issue (subject to, in tranches, certain milestones including the further issuance of Class A shares below). The warrant may be exercised, in whole or in part, at the discretion of the holder. The warrant terms initially included a ‘cashless’ exercise feature which was subsequently removed in June 2024. The warrants were treated as derivative liabilities at fair value through profit and loss between |
• | The proceeds were allocated on a fair value basis, firstly to the SEF warrant derivative liability and then the residual to the Class A preferred share obligation. Transaction costs were allocated on a relative fair value basis. |
• | OIC also provided commitments in November 2023 to purchase further tranches of preferred shares subject to achievement of certain milestones for which US$35 million was placed in escrow. The Company has not recognized any financial liability or allocation of proceeds in November 2023 or during the 2024 financial year for these preferred shares as the associated escrow deposit was not considered to be within the control of the Company. These commitments and escrow arrangements were subsequently modified in June 2024 on issuance of loan notes to OIC. |
• | Of the SEF warrants of up to 19.99% of the fully diluted Company shares on issue, 12.49% vested on completion of the initial US$35 million funding, a further 5% would vest on release of the US$35 million held in escrow (such release subject to certain conditions and milestones), and the final 2.5% would vest on release of the final US$40 million funding (such release subject to certain conditions and milestones including OIC investment committee approval). |
• | US$5 million in the form of Series B preferred shares in April 2024 and US$10 million advanced in the form of loan notes (Series 2024-A) in May and June 2024; |
• | In relation to the Class B Preferred Shares: mandatory redemption on November 3, 2028 aligned with the Class A Preferred Shares, with a 12% fixed accumulating dividend, and the Company may elect to redeem outstanding Class B Preferred Shares at an earlier date at its discretion subject to returning to the holder the greater of (i) a 1.75x MOIC return on face value, or (ii) a 12% IRR. |
• | In relation to the Series 2024-A Notes, maturity date of May 2027 concurrent with maturity of the New Debt Program / USD term loan; |
• | In relation to the Series 2024-A Notes, 12% interest comprising an 8.5% coupon rate payable monthly and a further 3.5% monthly payment in kind (which is capitalized progressively into the amount outstanding); |
• | In relation to the Series 2024-A Notes, progressive monthly repayments of principal commencing June 2026 – concurrent with the modified 2023 USD term loan; |
• | An exit premium payable on the Series 2024-A Notes of 2.0x invested capital plus a further $10 million, such exit premium being payable upon the earlier of a refinancing of the Series 2024-A notes, sale of the Company or maturity in May 2027, inclusive of any principal and interest payments to date. The repayment of the exit premium in full will be reduced or delayed in certain limited circumstances; |
• | The exit premium on the Class B Preferred Shares is reduced by an amount equal to the amount of cash dividends and redemption payments that have been paid to the holder(s) of Class B Preferred Shares; equally the amounts required to redeem the Class B Preferred Shares are reduced on account of payments made towards the exit premium, and where the amount required to redeem the Class B Preferred Shares is reduced to zero, the holder(s) of the Class B Preferred Shares will surrender those shares for no additional consideration; |
• | The Company obtained a modification of the 2023 USD term loan such that it would rank equally to the Series 2024-A notes issued; |
• | 434,708 US$0.01 SEF warrants to purchase a number of ordinary shares equivalent to 14.06% of ordinary shares issued calculated on a fully diluted basis (as defined in the OIC warrant) at the time of exercise, the terms of which are equivalent to the November 2023 SEF warrants; and |
• | Further, a modification of all OIC warrants outstanding as of June 2024 to remove a cashless exercise feature. This included OIC warrants previously issued in November 2023, April 2024 and May 2024. |
4.2.1 | Fair values and risk management |
30 June 2024 | Carrying amount | Fair value | ||||||||||||||||||||||
Fair value through profit and loss | Financial assets at amortized cost | Other financial liabilities | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||
$’000 | $’000 | $’000 | $’000 | |||||||||||||||||||||
Financial assets not measured at fair value | ||||||||||||||||||||||||
Receivables | — | 8,538 | — | 8,538 | — | — | — | — | ||||||||||||||||
Cash and cash equivalents | — | 3,705 | — | 3,705 | — | — | — | — | ||||||||||||||||
Restricted trust fund | — | 7,675 | — | 7,675 | — | — | — | — | ||||||||||||||||
— | 19,918 | — | 19,918 | |||||||||||||||||||||
Financial liabilities at fair value | ||||||||||||||||||||||||
Derivative liability – warrants | 531 | — | — | 531 | 531 | — | — | 531 | ||||||||||||||||
30 June 2024 | Carrying amount | Fair value | ||||||||||||||||||||||
Fair value through profit and loss | Financial assets at amortized cost | Other financial liabilities | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||
$’000 | $’000 | $’000 | $’000 | |||||||||||||||||||||
531 | — | — | 531 | |||||||||||||||||||||
Financial liabilities not measured at fair value | ||||||||||||||||||||||||
OIC Class A preferred shares (USD) | — | — | 46,377 | 46,377 | — | 52,474 | — | 52,474 | ||||||||||||||||
USD term loan | — | — | 78,468 | 78,468 | — | 94,903 | — | 94,903 | ||||||||||||||||
OIC Series 2024-A notes (USD) | — | — | 10,938 | 10,938 | — | 30,136 | — | 30,136 | ||||||||||||||||
OIC Class B preferred shares (USD) | — | 5,070 | 5,070 | — | 14,993 | — | 14,993 | |||||||||||||||||
Supplier finance arrangement | — | — | 14,013 | 14,013 | — | 14,013 | — | 14,013 | ||||||||||||||||
Payables | — | — | 60,440 | 60,440 | — | — | — | — | ||||||||||||||||
— | — | 215,306 | 215,306 | |||||||||||||||||||||
30 June 2023 | Carrying amount | Fair value | ||||||||||||||||||||||
Fair value | Financial assets at amortized cost | Other financial liabilities | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||
$’000 | $’000 | $’000 | $’000 | |||||||||||||||||||||
Financial assets not measured at fair value | ||||||||||||||||||||||||
Receivables | — | 6,430 | — | 6,430 | — | — | — | — | ||||||||||||||||
Cash and cash equivalents | — | 19,582 | — | 19,582 | — | — | — | |||||||||||||||||
Restricted trust fund | — | 14,677 | — | 14,677 | — | — | — | — | ||||||||||||||||
— | 40,689 | — | 40,689 | |||||||||||||||||||||
Financial liabilities not measured at fair value | ||||||||||||||||||||||||
Term loan (USD) | — | — | 70,833 | 70,833 | — | 90,645 | — | 90,645 | ||||||||||||||||
Term loan with customer | — | — | 4,523 | 4,523 | — | 4,523 | — | 4,523 | ||||||||||||||||
Supplier financing arrangement | — | — | 9,306 | 9,306 | — | 9,306 | — | 9,306 | ||||||||||||||||
Payables | — | — | 15,474 | 15,474 | — | — | — | — | ||||||||||||||||
— | — | 100,136 | 100,136 | |||||||||||||||||||||
Level 1: | The fair value of financial instruments traded in active markets (e.g. publicly traded derivatives and equity securities) is based on quoted market prices at the end of the reporting period. |
Level 2: | The fair value of financial instruments that are not traded in an active market (e.g. over–the–counter derivatives) is determined using valuation techniques which maximize the use of observable market data and rely as little as possible on entity-specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is included in level 2. |
Level 3: | If one or more of the significant inputs is not based on observable market data, the instrument is included in level 3. This is the case for unlisted equity securities and for instruments where risk gives rise to a significant unobservable adjustment. |
+/-5% fair value | $’000 Strengthening | $’000 Weakening | ||||
2024 | ||||||
Impact on loss before tax | (27) | 27 | ||||
Impact on equity | 27 | (27) | ||||
2023 | ||||||
Impact on loss before tax | — | — | ||||
Impact on equity | — | — | ||||
4.3 | Financial risk management |
4.3.1 | Market risk |
a) | Foreign currency risk |
2024 | EUR $’000 | USD $’000 | ||||
Cash and cash equivalent | 33 | 1,588 | ||||
Restricted trust fund | — | 7,284 | ||||
Trade receivables | 2,160 | 35 | ||||
Trade payables | (18,388) | (8,255) | ||||
Supplier finance arrangement | (7,624) | (1,344) | ||||
Borrowings | — | (93,945) | ||||
Balance sheet exposure | (23,819) | (94,637) | ||||
2023 | EUR $’000 | USD $’000 | ||||
Cash and cash equivalent | 632 | 7,422 | ||||
Restricted trust fund | — | 9,456 | ||||
Trade receivables | 2,409 | 400 | ||||
Trade payables | (419) | (813) | ||||
Supplier finance arrangement | (4,709) | (414) | ||||
Borrowings | — | (46,320) | ||||
Balance sheet exposure | (2,087) | (30,269) | ||||
2024 $’000 | 2023 $’000 | |||||
Net foreign exchange gain/(loss) | 2,115 | (305) | ||||
EUR $’000 | USD $’000 | |||||||||||
Strengthening | Weakening | Strengthening | Weakening | |||||||||
2024 | ||||||||||||
Impact on loss before tax | 1,191 | (1,191) | 4,732 | (4,732) | ||||||||
Impact on equity | 1,191 | (1,191) | 4,732 | (4,732) | ||||||||
2023 | ||||||||||||
Impact on loss before tax | 104 | (104) | 1,514 | (1,514) | ||||||||
Impact on equity | 104 | (104) | 1,514 | 1,514 | ||||||||
b) | Interest rate risk |
Variable interest rate 2024 $’000 | 2023 $’000 | Fixed interest rate 2024 $’000 | 2023 $’000 | Total 2024 $’000 | Total 2023 $’000 | |||||||||||||
Financial assets | ||||||||||||||||||
Cash | 3,705 | 19,582 | — | — | 3,705 | 19,582 | ||||||||||||
Restricted trust fund | 7,283 | 14,285 | 392 | 392 | 7,675 | 14,677 | ||||||||||||
Total financial assets | 10,988 | 33,867 | 392 | 392 | 11,380 | 34,259 | ||||||||||||
Borrowings and other financial liabilities | ||||||||||||||||||
Term loan with customer | — | — | — | 4,523 | — | 4,523 | ||||||||||||
Supplier finance arrangement | 14,013 | 9,306 | — | — | 14,013 | 9,306 | ||||||||||||
OIC Class A preferred shares (USD) | — | 52,474 | — | 52,474 | — | |||||||||||||
OIC Series 2024-A notes (USD) | — | — | 30,136 | — | 30,136 | — | ||||||||||||
OIC Class B preferred shares (USD) | — | — | 14,993 | — | 14,993 | — | ||||||||||||
USD term loan | — | — | 94,903 | 90,645 | 94,903 | 90,645 | ||||||||||||
Total financial liabilities | 14,013 | 9,306 | 192,506 | 95,168 | 206,519 | 104,474 | ||||||||||||
Profit or loss for the year | ||||||
Effect in thousands of AUD | 100 bp increase | 100 bp decrease | ||||
30 June, 2024 | ||||||
Supplier finance arrangement | (140) | 140 | ||||
30 June, 2023 | ||||||
Supplier finance arrangement | (93) | 93 | ||||
4.3.2 | Credit risk |
4.3.3 | Liquidity risk |
On demand $’000 | < 3 months $’000 | 3-12 months $’000 | 1-5 years $’000 | > 5 years $’000 | Total $’000 | |||||||||||||
2024 | ||||||||||||||||||
Supplier finance arrangement | 14,013 | — | — | — | — | 14,013 | ||||||||||||
Lease liabilities | — | 173 | 532 | 3,096 | 3,965 | 7,766 | ||||||||||||
OIC Class A preferred shares (USD) | — | — | — | 52,474 | — | 52,474 | ||||||||||||
OIC Series 2024-A notes (USD) | — | — | — | 30,136 | — | 30,136 | ||||||||||||
OIC Class B preferred shares (USD) | — | — | — | 14,993 | — | 14,993 | ||||||||||||
USD term loan | — | — | — | 94,903 | — | 94,903 | ||||||||||||
Payables | 45,247 | — | — | 15,193 | — | 60,440 | ||||||||||||
59,260 | 173 | 532 | 210,795 | 3,965 | 274,725 | |||||||||||||
2023 | ||||||||||||||||||
Supplier finance arrangement | 9,306 | — | — | — | — | 9,306 | ||||||||||||
Term loan with customer | — | — | 4,523 | — | — | 4,523 | ||||||||||||
Lease liabilities | — | 158 | 487 | 2,830 | 4,538 | 8,013 | ||||||||||||
USD term loan | — | — | — | 90,645 | — | 90,645 | ||||||||||||
Payables | 15,474 | — | — | — | — | 15,474 | ||||||||||||
24,780 | 158 | 5,010 | 93,475 | 4,538 | 127,961 | |||||||||||||
4.4 | Contributed equity |
Issued share capital | Number of ordinary shares outstanding | |||||
As at July 1, 2021 (EUR1.00) | Note | 100 | ||||
As at July 1, 2022 (EUR1.00) | 100 | |||||
Ordinary shares issued (EUR1.00) | 24,900 | |||||
At July 1, 2023 | 25,000 | |||||
Surrender by holder to the Company | (25,000) | |||||
Merger Transaction | ||||||
- USD$0.0001 shares issued to Carbon Revolution Limited shareholders in exchange for their shares | 6.7 | 1,367,211 | ||||
- USD$0.0001 shares issued to Twin Ridge shareholders in exchange for their shares | 6.7 | 506,473 | ||||
- USD$0.0001 shares issued to Yorkville on establishment of the committed equity facility | 6.7 | 1,500 | ||||
USD$0.0001 shares issued for marketing services | 4.5 | 10,000 | ||||
As at June 30, 2024 | 1,885,184 | |||||
June 30, 2024 $’000 | June 30, 2023 $’000 | |||||
Ordinary shares – $USD0.0001 par value (2023: EUR1.00) | — | — | ||||
Ordinary shares – share premium | — | — | ||||
Ordinary shares – restricted | — | — | ||||
Total share capital | — | — | ||||
4.4.1 | Information about contributed equity |
4.5 | Share-based payment plan arrangements |
4.6 | Reserves |
2024 $’000 | 2023 $’000 | |||||
Share-based payments | 1,905 | 7,695 | ||||
Share buyback | — | (311) | ||||
Foreign currency translation | 85 | (218) | ||||
1,990 | 7,166 | |||||
4.6.1 | Information about reserves |
4.7 | Capital raising transaction costs |
2024 $’000 | 2023 $’000 | |||||
Capital raising transaction costs recognized in the Consolidated Statements of Profit or Loss and Other Comprehensive Income | 31,584 | 24,746 | ||||
Finance income recognised in the Consolidated Statements of Profit or Loss and Other Comprehensive Income | (538) | — | ||||
31,046 | 24,746 | |||||
Capital raising transaction costs recognized in trade payables | 22,938 | 541 | ||||
Capital raising transaction costs recognized in accruals | 1,448 | 5,716 | ||||
Capital raising transaction costs recognized in provisions | — | 9,459 | ||||
Capital raising transaction costs recognized in the operating cash flow | 11,712 | 9,030 | ||||
Capital raising transaction costs in equity | 10,654 | — | ||||
5 | Taxes |
5.1 | Income tax expense |
2024 $’000 | 2023 $’000 | |||||
Consolidated Statements of Profit or Loss and Other Comprehensive Income | ||||||
Current income tax charge / benefit | — | — | ||||
Adjustment for current tax relating to prior periods | — | — | ||||
Deferred income tax relating to the origination and reversal of temporary differences | — | — | ||||
— | — | |||||
2024 $’000 | 2023 $’000 | |||||
The prima facie tax benefit on loss before tax differs from the income tax expense as follows: | ||||||
Loss before tax | (221,083) | (79,223) | ||||
Benefit at the Irish statutory income tax rate of 25% (2023 and 2022: 30% at the Australian statutory income tax rate)* | 55,271 | 23,767 | ||||
Tax impact of: | ||||||
Non-deductible expenses | (13,599) | (4,859) | ||||
Non-assessable income | 1,796 | — | ||||
Impact of different tax rates in foreign jurisdictions | 8,641 | 29 | ||||
Current year taxable loss not recognized | (52,109) | (18,937) | ||||
Income tax expense | — | — | ||||
* | Carbon Revolution PLC is domiciled in Ireland pursuant to the Transaction. Prior comparatives reflect the Australian corporate tax rate of 30%, being the tax rate of Carbon Revolution Limited as predecessor. Refer to note 6.7 for details of the Transaction. |
5.2 | Deferred taxes |
5.2.1 | Research and development tax credits |
5.2.2 | Interest limitation rules and disallowed amounts |
5.3.1 | Recognized deferred tax assets and liabilities in the Consolidated Statements of Financial Position |
2024 $’000 | 2023 $’000 | |||||
Deferred tax liabilities relating to temporary differences: | ||||||
Intangible assets | — | (4,746) | ||||
Property, plant and equipment | — | (12,841) | ||||
Receivables | — | — | ||||
Right of use assets | — | (2,234) | ||||
Other | (1,567) | — | ||||
(1,567) | (19,821) | |||||
Deferred tax assets related to temporary differences: | ||||||
Provisions and accruals | 805 | 6,981 | ||||
Capital raising transaction costs | — | 7,833 | ||||
Tax losses | — | 2,682 | ||||
Lease liability | — | 2,234 | ||||
Other | 762 | 91 | ||||
Total | 1,567 | 19,821 | ||||
Net deferred tax liability | — | — | ||||
Less: temporary differences not previously recognized | — | — | ||||
Net deferred tax recognized in the Consolidated Statements of Financial Position | — | — | ||||
5.3.2 | Unrecognized deferred tax assets |
2024 $’000 | 2023 $’000 | |||||
Provisions and accruals | 8,433 | — | ||||
Property, plant and equipment | 15,535 | — | ||||
2024 $’000 | 2023 $’000 | |||||
Capital raising transaction costs | 7,135 | — | ||||
Other deductible temporary differences | 3,283 | — | ||||
Tax losses | 66,793 | 51,843 | ||||
R&D tax credits | 34,883 | 27,948 | ||||
FRT disallowed amounts | 4,376 | — | ||||
140,438 | 79,791 | |||||
5.4 | Carry forward unrecognized tax losses, research and development tax credits, and FRT disallowed amounts |
2024 $’000 | Expiry date | 2023 $’000 | Expiry date | |||||||||
Tax losses | 66,793 | — | 51,843 | — | ||||||||
R&D tax credits | 34,883 | — | 27,948 | — | ||||||||
FRT disallowed amounts | 4,376 | 2039 | — | — | ||||||||
6 | Other notes |
6.1 | Information about subsidiaries |
Name | Principal activities | Country of incorporation | 2024 | % equity interest 2023 | ||||||||
Carbon Revolution Pty Ltd | Carbon fiber wheels | Australia | 100* | — | ||||||||
Carbon Revolution Operations Pty Ltd | Carbon fiber wheels | Australia | 100 | 100 | ||||||||
Carbon Revolution Technology Pty Ltd | N/A | Australia | 100 | 100 | ||||||||
Carbon Revolution (USA) LLC | Carbon fiber wheels | United States | 100 | 100 | ||||||||
Carbon Revolution (UK) Limited | Carbon fiber wheels | United Kingdom | —** | 100 | ||||||||
Poppettell Merger Sub | Twin Ridge merged with and into this entity | Cayman Islands | 100 | — | ||||||||
* | Carbon Revolution Pty Ltd, formerly Carbon Revolution Limited, was the ultimate parent of the Carbon Revolution group of companies in 2023. |
** | Carbon Revolution (UK) Limited was liquidated on August 15, 2023. |
6.2 | Directors and Key management personnel |
6.2.1 | Directors |
2024 $ | 2023 $ | |||||
Compensation by category | ||||||
Short-term employment benefits | 1,901,543 | 1,525,844 | ||||
Share-based payment | 55,419 | — | ||||
Post-employment benefits | 59,151 | 74,059 | ||||
2,016,113 | 1,599,903 | |||||
6.2.2 | Directors and Key management personnel |
2024 $ | 2023 $ | |||||
Compensation by category | ||||||
Short-term employment benefits | 2,297,211 | 2,211,445 | ||||
Share-based payment | 91,111 | — | ||||
Post-employment benefits | 87,701 | 99,352 | ||||
2,476,023 | 2,310,797 | |||||
6.3 | Transactions with related parties |
6.4 | Unrecognized items |
6.4.1 | Guarantees |
6.4.2 | Capital commitments |
6.4.3 | Contingent liabilities |
6.5 | Changes in accounting policies |
• | Disclosure of Accounting Policies – Amendments to IAS 1 and IFRS Practice Statement 2 |
○ | Although the amendments did not result in any changes to the accounting policies themselves, they impacted the accounting policy information disclosed in the financial statements. The amendments |
• | Deferred Tax related to Assets and Liabilities arising from a Single Transaction – Amendments to IAS 12 |
○ | Carbon Revolution applied amendments that narrow the scope of the initial recognition exemption to exclude transactions that give rise to equal and offsetting temporary differences. |
• | International Tax Reform – Pillar Two Model Rules – Amendments to IAS 12 |
○ | The amendments provide a temporary mandatory exception from deferred tax accounting for the top-up tax and accounts for it as a current tax when it is incurred, which is effective immediately, and require new disclosures about the Pillar Two exposure. The mandatory exception applies retrospectively However, because no new legislation to implement the top-up tax was enacted or substantively enacted at June 30, 2024 in any jurisdiction in which Carbon Revolution operates and no related deferred tax was recognized at that date, the retrospective application has no impact on the Carbon Revolution’s financial statements. |
○ | Global minimum top-up tax – The Group operates in Australia, which has enacted the new legislation to implement the global minimum top-up tax and expects to be subject to the top-up tax in relation to its operations, where the statutory tax rate is 30 percent. However, since the newly enacted legislation in Australia is only effective from January 1, 2024, there is no current tax impact for the year ended June 30, 2024. The Group has applied a temporary mandatory relief from deferred tax accounting for the impacts of the top-up tax and accounts for it as current tax when it is incurred (see Note 5.2). |
a. | IFRS 17 Insurance Contracts |
6.6 | Accounting standards issued but not yet effective at June 30, 2024 |
Standard and Interpretation | Effective for annual reporting periods beginning on or after | Expected to be initially applied in the financial year ending | ||||||
Classification of Liabilities as Current or Non-current – Amendments to IAS 1 | 1 January 2024 | 30 June 2025 | ||||||
Lease Liability in a Sale and Leaseback – Amendments to IFRS 16 | 1 January 2024 | 30 June 2025 | ||||||
Supplier Finance Arrangements – Amendments to IAS 7 and IFRS 7 | 1 January 2024 | 30 June 2025 | ||||||
Lack of Exchangeability – Amendments to IAS 21 | 1 January 2025 | 30 June 2026 | ||||||
6.7 | Capital Reorganization |
• | Carbon Revolution Limited’s existing shareholders have the greatest voting interest in the combined entity; |
• | Carbon Revolution Limited’s directors represent the majority of the board of directors of the combined company and Carbon Revolution’s senior management will be the senior management of the combined company following consummation of the Transaction; and |
• | Carbon Revolution Limited is the larger entity based on historical operating activity and its employee base. |
a) | 1,367,211 ordinary shares in the Company were issued to existing Carbon Revolution Limited shareholders in exchange for their 213,029,945 ordinary shares in Carbon Revolution Limited that were cancelled. |
b) | The Company issued 506,473 ordinary shares to Twin Ridge shareholders in exchange for their existing Twin Ridge shares, as well as 5,107,842 private placement warrants and 7,098,819 public warrants having their warrants automatically exchanged by Carbon Revolution PLC of the obligations under such warrants, including to become exercisable in respect of Ordinary Shares instead of Twin Ridge ordinary shares. The Company’s warrants are exercisable at US$11.50 for one-tenth of an ordinary share and expire in November 2028. The public and private warrants are considered to be a derivative financial liability and measured at fair value through profit and loss. |
c) | Effectuation of a 10-to-1 consolidation of the ordinary shares of the Company as reflected in the number of shares shown in b) and d). |
d) | 1,500 ordinary shares in the Company were issued to Yorkville as a commitment fee to secure a US$60M committed equity facility (“CEF”). As at June 30, 2024, the Company has not utilized the facility. The above steps a to d happened concurrently. |
e) | Immediately subsequent to the issuances, the Company undertook a capital reduction under the Irish Companies Act 2014 which had the effect of transferring share capital / share premium to accumulated losses with no change to the number of shares on issue. |
f) | On completion of the Transaction in November 2023, all historical share-based payment plans of Carbon Revolution Limited were cancelled for no consideration. |
- | The amount recognized as issued ordinary shares in these consolidated financial statements of Carbon Revolution PLC has been determined by adding the fair value of the deemed issuance of shares to Twin Ridge shareholders and Carbon Revolution shareholders. Also, the accumulated losses and other equity balances in the comparative periods have been restated to reflect the impact of the capital reorganization. |
- | The equity structure (number of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization, refer to Note 4.4. |
- | The excess of the fair value of the Company’s shares issued to Twin Ridge over the net liabilities incurred have been accounted as a listing expense. |
- | The settlement of pre-existing relationship between the Company and Twin Ridge has been determined using fair value method. |
- | The assets and liabilities of Carbon Revolution Limited have been recognized and measured in the Company’s consolidated financial statements at their pre-combination carrying amounts; |
- | Accumulated losses and other equity balances are additionally adjusted to give effect to the Irish capital reduction which received court’s approval on 19th January 2024 to reflect the equity structure of the Company under Irish law. |
- | The Consolidated Statements of Profit or Loss and Other Comprehensive Income reflects that of Carbon Revolution Limited for the full period together with the post-acquisition results of the Company from the Closing Date of the Transaction. Loss per share of Carbon Revolution Limited is restated such that the denominator of historical loss per share and weighted average shares issued is adjusted by the exchange ratio established in the Transaction, refer to Note 2.5. |
Fair value of equity consideration issued | $ | ||
506,473 ordinary shares issued to Twin Ridge shareholders | (10,653,571) | ||
Settlement of pre-existing relationship | (809,364) | ||
Total consideration | (11,462,935) | ||
Twin Ridge net assets acquired / (liabilities assumed) | |||
Net cash proceeds from Twin Ridge | 1,085,063 | ||
Warrant liabilities | (1,447,861) | ||
Payables | (13,888,485) | ||
Settlement of pre-existing relationship | 809,364 | ||
Net liabilities assumed by CRL | (13,441,919) | ||
Listing expenses | 24,904,854 | ||
6.8 | Subsequent events |
7 | Statutory information |
7.1 | Auditor Remuneration |
2024 | 2023 | |||||
Audit services | 2,458,700 | 193,135 | ||||
Non-audit services | 40,000 | 40,833 | ||||
2,498,700 | 233,968 | |||||
Note | June 30, 2024 AU $’000 | June 30, 2023 AU $’000 | |||||||
Current assets | |||||||||
Debtors (amounts falling due within one year) | 3.1 | 2,610 | — | ||||||
Other receivables | 3.1 | — | 40 | ||||||
Total current assets | 2,610 | 40 | |||||||
Debtors | 3.1 | — | — | ||||||
Investment in subsidiary | — | — | |||||||
Total non-current assets | — | — | |||||||
Total assets | 2,610 | 40 | |||||||
Current liabilities | |||||||||
Creditors (amounts falling due within one year) | 3.2 | 1,083 | — | ||||||
Total current liabilities | 1,083 | — | |||||||
Non-current liabilities | |||||||||
Borrowings | 4.1 | 51,445 | — | ||||||
Derivative liabilities – Warrants | 4.1 | 531 | — | ||||||
Total non-current liabilities | 51,976 | — | |||||||
Total liabilities | 53,059 | — | |||||||
Net (liabilities) / assets | (50,449) | 40 | |||||||
Equity (Deficit) | |||||||||
Share capital | 5 | — | 40 | ||||||
Share premium | 5 | — | — | ||||||
Warrants | 7,504 | — | |||||||
Reserves | 5 | 710 | — | ||||||
Accumulated losses | (58,663) | — | |||||||
Total (deficit) equity | (50,449) | 40 | |||||||
![]() | ![]() | June 6, 2025 | ||||
Dale McKee | Matti Masanovich | |||||
Director | Director | |||||
Note | Share Capital AU $’000 | Share Premium AU $’000 | Share based payment reserve AU $’000 | Warrants AU $’000 | Other reserves AU $’000 | Accumulated losses* AU $’000 | Total equity (deficit) AU $’000 | |||||||||||||||||
Balance as of July 1, 2022 | — | — | — | — | — | — | — | |||||||||||||||||
Loss after tax for the year | — | — | — | — | — | — | — | |||||||||||||||||
Total comprehensive loss for the year | — | — | — | — | — | — | — | |||||||||||||||||
Issue of share capital | 40 | — | — | — | — | — | 40 | |||||||||||||||||
Balance as of June 30, 2023 | 40 | — | — | — | — | — | 40 | |||||||||||||||||
— | ||||||||||||||||||||||||
Balance as of July 1, 2023 | 40 | — | — | — | — | — | 40 | |||||||||||||||||
Loss after tax for the year | — | — | — | — | — | (98,106) | (98,106) | |||||||||||||||||
Other comprehensive loss for the year | (1,193) | — | (1,193) | |||||||||||||||||||||
Total comprehensive loss for the year | — | — | — | — | (1,193) | (98,106) | (99,299) | |||||||||||||||||
Issue of share capital pursuant to the Transaction | (40) | 39,443 | — | — | — | — | 39,403 | |||||||||||||||||
Irish capital reduction | — | (39,443) | — | — | — | 39,443 | — | |||||||||||||||||
Issue of warrants | — | — | — | 7,504 | — | — | 7,504 | |||||||||||||||||
Equity-settled share-based payment to non-employee | — | — | 1,903 | — | — | — | 1,903 | |||||||||||||||||
Balance as of June 30, 2024 | — | — | 1,903 | 7,504 | (1,193) | (58,663) | (50,449) | |||||||||||||||||
* | Comparative periods have been re-stated with the capital structure of the Company being the continuing legal parent. Refer to note 6.7 in the Consolidated Financial Statements. |
Basis of preparation |
1.1 | Basis of preparation |
• | A Cash Flow Statement and related notes; |
• | Disclosures in respect of transactions with wholly owned subsidiaries; |
• | The effects of new but not yet effective IFRSs; |
• | Disclosures in respect of the compensation of Key Management Personnel; |
• | Certain disclosures regarding revenue; and |
• | Certain disclosures regarding leases. |
1.2 | Significant accounting judgements, estimates and assumptions |
1.3 | Change in accounting policy |
• | Classification of Liabilities as Current or Non-current (Amendments to IAS 1) and Non-current Liabilities with Covenants (Amendments to IAS 1) from 1 January 2024. The amendments apply retrospectively. They |
1.4 | Directors |
2. | Investment in subsidiaries |
3. | Debtors and Creditors |
3.1 | Receivables |
2024 $’000 | 2023 $’000 | |||||
Current | ||||||
Debtors | — | — | ||||
Other receivables | 1,056 | 40 | ||||
Prepayments | 1,275 | — | ||||
Income tax receivable | 279 | — | ||||
2,610 | 40 | |||||
Non-current | ||||||
Intercompany loans (amounts falling due more than a year) | 53,312 | — | ||||
Allowance for impairment losses | (53,312) | — | ||||
— | — | |||||
Total Receivables | 2,610 | 40 | ||||
3.1.1 | Information about debtors |
3.2 | Creditors |
2024 $’000 | 2023 $’000 | |||||
Current | ||||||
Unsecured liabilities | ||||||
Trade payables | 9 | — | ||||
Accruals | 740 | — | ||||
Interest accrual | 257 | — | ||||
Intercompany loans | 77 | |||||
Total Creditors | 1,083 | — | ||||
3.2.1 | Information about creditors |
4. | Capital structure and financing |
4.1 | Borrowings and other financial liabilities |
Interest rate % | Maturity | 2024 $’000 | 2023 $’000 | |||||||||
Non-current borrowings and other financial liabilities | ||||||||||||
Unsecured | ||||||||||||
OIC Class A preferred shares (USD) | 12.00% | November 2028 | 46,376 | — | ||||||||
OIC Class B preferred shares (USD) | 12.00% | November 2028 | 5,069 | — | ||||||||
Non-current borrowings | 51,445 | — | ||||||||||
Derivative liabilities – Warrants | 531 | — | ||||||||||
51,976 | ||||||||||||
5. | Share Capital |
6. | Other notes |
6.1 | Transactions with related parties |
6.2 | Unrecognized items |
6.2.1 | Guarantees |
6.2.2 | Capital commitments |
6.2.3 | Contingent liabilities |
6.3 | Capital Reorganization |
7. | Statutory information |
8. | Subsequent events |
Approval of financial statements |